Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Jan. 01, 2022	Jan. 02, 2021
Cash flows from operating activities:
Net income (loss)	$ 20,889	$ 10,989	$ (8,869)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	1,041	1,102	1,386
Gain on sale of assets	(219)	(2,420)	0
Remeasurement of contingent consideration	(88)	(1,713)	0
Impairment of right of use assets and related costs	0	0	2,231
Change in fair value of contingent consideration	0	52	145
Equity compensation expense from awards issued	1,582	1,358	1,108
Effect of excess tax deduction on equity awards	206	20	0
Provision for losses on accounts receivable	(1,038)	(208)	7,911
Deferred income tax expense (benefit)	2,054	2,542	(3,712)
Amortization of right of use assets	1,001	1,057	1,490
Changes in operating assets and liabilities:
Accounts receivable	(1,509)	(14,710)	15,947
Prepaid expenses and other current assets	(2,350)	1,838	(162)
Net of transit accounts receivable and payable	5,433	(1,317)	2,757
Deposits	3	(7)	41
Accounts payable and accrued expenses	4,919	1,518	1,587
Accrued payroll and related costs	24	149	4,557
Right of use liabilities	(1,642)	(1,919)	(1,529)
Income taxes payable	(276)	436	(304)
Deferred revenue	(2,299)	3,020	52
Total adjustments and changes in operating assets and liabilities	7,394	(10,074)	34,113
Net cash provided by operating activities	28,283	915	25,244
Cash flows from investing activities:
Property and equipment acquired	(889)	(568)	(460)
Payments for business acquired	(4,150)	0	0
Proceeds from sale of assets	219	6,859	0
Net cash (used in) provided by investing activities	(4,820)	6,291	(460)
Cash flows from financing activities:
Borrowings under line of credit	105,184	110,481	73,238
Repayments under line of credit	(110,552)	(108,220)	(96,109)
Issuance of stock for employee stock purchase plan	408	137	208
Changes in finance lease obligations	(508)	(415)	(394)
Contingent consideration paid	(99)	(494)	(345)
Common stock repurchase	(17,560)	(9,043)	(2,230)
Net cash used in financing activities	(23,127)	(7,554)	(25,632)
Effect of exchange rate changes on cash and cash equivalents	(232)	(151)	(265)
Increase (decrease) in cash and cash equivalents	104	(499)	(1,113)
Cash and cash equivalents at beginning of period	235	734	1,847
Cash and cash equivalents at end of period	339	235	734
Supplemental cash flow information:
Interest	297	417	1,026
Income taxes	5,095	1,010	264
Non-cash investing activities:
Contingent consideration relating to acquisitions	1,927	0	0
Value of shares issued pursuant to acquisitions	631	0	0
Fixed assets acquired in acquisitions	5	0	0
Non-cash financing activities:
Issuance of accrued share-based compensation	0	580	492
Right of use assets obtained in exchange for lease obligations	$ 3,047	$ 1,832	$ 258